Genmab AS

Genmab AS Rule of 40

The Rule of 40 of Genmab AS (GMAB) as of Oct 12, 2026 is -49.10 %. In the previous year, Rule of 40 was 61.81 % — a change of -179.45% (lower).

Rule of 40

-49.10 %

YoY

-179.45%

Last updated:

Rule of 40 of Genmab AS is 2025 -49.10 % . Rule of 40 of Genmab AS was 2024 61.81 % . It decreases by -179.45% lower compared to the previous year.

The Genmab AS Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
73.52 USD
Jan 1, 2019
126.54 USD
Jan 1, 2020
150.86 USD
Jan 1, 2021
18.33 USD
Jan 1, 2022
115.54 USD
Jan 1, 2023
45.87 USD
Jan 1, 2024
61.81 USD
Jan 1, 2025
-49.10 USD
The Genmab AS Rule of 40 history
YEARRule of 40YoY
-49.10 %-179.45%
61.81 %+34.73%
45.87 %-60.29%
115.54 %+530.32%
18.33 %-87.85%
150.86 %+19.22%
126.54 %+72.13%
73.52 %-15.57%
87.07 %-26.37%
118.26 %+21.04%
97.70 %—
Access this data via the Eulerpool API

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Rule of 40 of Genmab AS is -49.10 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Genmab AS since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

Quality — Genmab AS

All Key Metrics — Genmab AS